264 related articles for article (PubMed ID: 23466488)
1. Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats.
Badole SL; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Jangam GB; Ghule AE; Raut CG; Khedkar VM; Coutinho EC
Chem Biol Interact; 2013 Apr; 203(2):530-41. PubMed ID: 23466488
[TBL] [Abstract][Full Text] [Related]
2. Cycloart-23-ene-3β, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach.
Badole SL; Mahamuni SP; Bagul PP; Khose RD; Joshi AC; Ghule AE; Bodhankar SL; Raut CG; Khedkar VM; Coutinho EC; Wagh NK
Eur J Pharmacol; 2013 Jan; 698(1-3):470-9. PubMed ID: 23117087
[TBL] [Abstract][Full Text] [Related]
3. Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats.
Badole SL; Chaudhari SM; Bagul PP; Mahamuni SP; Khose RD; Joshi AC; Raut CG; Zanwar AA
PLoS One; 2013; 8(8):e72817. PubMed ID: 24023648
[TBL] [Abstract][Full Text] [Related]
4. Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
Samocha-Bonet D; Wong O; Synnott EL; Piyaratna N; Douglas A; Gribble FM; Holst JJ; Chisholm DJ; Greenfield JR
J Nutr; 2011 Jul; 141(7):1233-8. PubMed ID: 21593352
[TBL] [Abstract][Full Text] [Related]
5. Huang-lian-jie-du-decoction modulates glucagon-like peptide-1 secretion in diabetic rats.
Yu YL; Lu SS; Yu S; Liu YC; Wang P; Xie L; Wang GJ; Liu XD
J Ethnopharmacol; 2009 Jul; 124(3):444-9. PubMed ID: 19497359
[TBL] [Abstract][Full Text] [Related]
6. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
[TBL] [Abstract][Full Text] [Related]
7. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
Cani PD; Daubioul CA; Reusens B; Remacle C; Catillon G; Delzenne NM
J Endocrinol; 2005 Jun; 185(3):457-65. PubMed ID: 15930172
[TBL] [Abstract][Full Text] [Related]
8. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
[TBL] [Abstract][Full Text] [Related]
9. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
10.
Boye A; Barku VYA; Acheampong DO; Ofori EG
Biomed Res Int; 2021; 2021():9920826. PubMed ID: 34341763
[TBL] [Abstract][Full Text] [Related]
11. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
[TBL] [Abstract][Full Text] [Related]
12. Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.
Tanaka H; Yoshida S; Minoura H; Negoro K; Shimaya A; Shimokawa T; Shibasaki M
Life Sci; 2014 Jan; 94(2):115-21. PubMed ID: 24269216
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.
Mu J; Petrov A; Eiermann GJ; Woods J; Zhou YP; Li Z; Zycband E; Feng Y; Zhu L; Roy RS; Howard AD; Li C; Thornberry NA; Zhang BB
Eur J Pharmacol; 2009 Nov; 623(1-3):148-54. PubMed ID: 19765579
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.
Manaer T; Yu L; Zhang Y; Xiao XJ; Nabi XH
J Ethnopharmacol; 2015 Jul; 169():269-74. PubMed ID: 25922265
[TBL] [Abstract][Full Text] [Related]
15. Glucagon receptor antagonism promotes the production of gut proglucagon-derived peptides in diabetic mice.
Lang S; Wei R; Wei T; Gu L; Feng J; Yan H; Yang J; Hong T
Peptides; 2020 Sep; 131():170349. PubMed ID: 32561493
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model.
Chang G; Zhang P; Ye L; Lu K; Wang Y; Duan Q; Zheng A; Qin S; Zhang D
Eur J Pharmacol; 2013 Oct; 718(1-3):105-13. PubMed ID: 24041927
[TBL] [Abstract][Full Text] [Related]
18. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
Medras ZJH; El-Sayed NM; Zaitone SA; Toraih EA; Sami MM; Moustafa YM
Pharmacol Rep; 2018 Apr; 70(2):233-242. PubMed ID: 29475006
[TBL] [Abstract][Full Text] [Related]
19. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
20. Combination of mangiferin and dipeptidyl peptidase-4 inhibitor sitagliptin improves impaired glucose tolerance in streptozotocin-diabetic rats.
Hou J; Zheng D; Fan K; Yu B; Xiao W; Ma J; Jin W; Tan Y; Wu J
Pharmacology; 2012; 90(3-4):177-82. PubMed ID: 22948814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]